U.S. market Closed. Opens in 14 hours 48 minutes

CGON | CG Oncology, Inc. Common stock Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-31
Revenue204.00K191.00K10.36M
Cost of RevenueN/A15.00K10.00K
Gross Profit204.00K176.00K10.35M
Operating Expenses55.65M35.42M22.95M
Selling, General & Admin9.90M6.39M4.63M
Research & Development45.75M29.03M18.32M
Other Operating ExpensesN/A-196.00K218.00K
Operating Income-55.45M-35.25M-12.61M
Other Expenses / Income6.84M-197.00K-233.00K
Before Tax Income-48.61M-35.44M-12.84M
Income Tax ExpensesN/AN/AN/A
Net Income-48.61M-35.44M-12.84M
Interest ExpensesN/A1.00K451.00K
Basic Shares Outstanding4.33M66.64M66.64M
Diluted Shares Outstanding4.33M66.64M66.64M
EBITDA-55.43M-35.23M-12.38M
EBITDA Margin-27,172.55%-18,445.55%-119.50%
EBIT-48.61M-35.44M-12.39M
EBIT Margin-23,826.96%-18,556.02%-119.60%
Financial Year End2023-12-312022-12-312021-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙